Nephrolithiasis patients undergoing ureteroscopy are at risk for opioid dependence due to the nature of the disease, multiple provider encounters across an acute episode, and surgical and stent-related pain. The objective of this study was to evaluate an Enhanced Recovery After Surgery (ERAS) care pathway that provides standardization for the anesthetic care and post-operative management of patients undergoing ureteroscopy and stent placement with a goal towards minimizing opioid exposure.
INTRODUCTION AND OBJECTIVES:
Nephrolithiasis patients undergoing ureteroscopy are at risk for opioid dependence due to the nature of the disease, multiple provider encounters across an acute episode, and surgical and stent-related pain. The objective of this study was to evaluate an Enhanced Recovery After Surgery (ERAS) care pathway that provides standardization for the anesthetic care and post-operative management of patients undergoing ureteroscopy and stent placement with a goal towards minimizing opioid exposure.
METHODS: Consecutive patients undergoing ureteroscopy and stent placement were identified leading up to and after implementation of the ERAS protocol. Urinary symptoms, pain, and PROMIS survey scores were obtained before surgery. The ERAS protocol included preoperative non-opioid premedication, minimal intraoperative and post-anesthesia opioids, and explicitly written non-opioid discharge medications. Patients were contacted at 48-72 hours and seven days postop to obtain follow up survey scores. Unanticipated phone calls, emergency room visits, and need for opioid refills were obtained. Collected data was compared between the two study populations.
RESULTS: Among 53 patients enrolled (29 pre-intervention, 24 ERAS), mean age was 54.2 years and 57% were women. There was no difference in gender or age between the groups. On univariate and multivariable analyses, there were no significant differences between preoperative and postoperative survey results (Figure 1 ). The difference in morphine equivalent dosages was significant (p<0.001). There were no significant differences seen between pre-or post-ERAS groups for additional opioid requests, unexpected patient phone calls, or emergency room visits.
CONCLUSIONS: Implementation of this ERAS protocol for patients undergoing ureteroscopy and ureteral stenting resulted in reduction to almost near-zero levels of opioid prescribing with fewer post-operative phone calls and no adverse effect on patient reported outcomes, emergency room visits, or opioid refills.
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MP39-13 FORGOTTEN URETERAL STENT: MULTIPLE SAFEGUARDS AND SHARED RESPONSIBILITY TO MINIMIZE THE RISK
Oscar Fugita*, Sao Paulo, Brazil; Fernando Gonzales, Andres Avalos, Santiago, Chile; Paulo Kawano, Joao Luiz Amaro, Botucatu, Brazil; Ana Maria Cardenaz-Ortiz, Bogota, Colombia; Luiz Takano Araujo, S ao Paulo, Brazil; Alfredo Luna, Cartagena, Colombia; Marcelo Baptistussi, Ribeirao Preto, Brazil; Mariano Gonzalez, Norberto Bernardo, Buenos Aires, Argentina INTRODUCTION AND OBJECTIVES: Ureteral stents (US) are indispensable tools in a wide range of urological scenarios. Despite meticulous vigilance, ureteral stents may be forgotten, frequently entailing significant complications. A variety of ureteral stents tracking protocols has been proposed in an attempt to prevent this potential catastrophic event with modest adherence and results in the clinical scenario At a time when paternalism and shared decision making is widely discussed, the role of the patient in this process should be better discussed. We present a multi-institutional high volume stone centers experience on the management of forgotten ureteral stents and a suggestion to include the patients responsibility in a protocol to prevent cases of forgotten ureteral stents.
METHODS: We retrospectively reviewed the charts of 5,278 patients that had a ureteral stent managed at six high volume stone centers. Some of the patients were referred to these centers due to the complexity of the cases. All cases of forgotten ureteral stents (US) (defined as a catheter left in situ for more than 6 months after the insertion or that was already calcified even before that time) were identified. The responsibility for the overdue of the US (institution or patient) was based on the presence or absence of a telephone call or mail reminder registration on the patient medical record. At all institutions, an informed consent was applied before surgery and at discharge. Data at the informed consent included information about the symptoms related to the stent, possible complications related to the stent, need for stent removal. deadline for the stent removal and telephone number for contact.
RESULTS: Forgotten US were identified in 81 of the 5,278 patients. Some cases may have been lost as only those patients that returned to the departments were included. Some of the patients were only referred to our institutions because of the complex calcified stent management. Forgetfulness to retrieve the US was attributed to the Vol. 201, No. 4S, Supplement, Saturday, May 4, 2019 THE JOURNAL OF UROLOGY Ò e549
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